Crucial Fact

  • Her favourite word was fact.

Last in Parliament November 2005, as Liberal MP for Edmonton Centre (Alberta)

Lost her last election, in 2006, with 39% of the vote.

Statements in the House

Pest Control Products Act June 12th, 2002

moved that Bill C-53, An Act to protect human health and safety and the environment by regulating products used for the control of pests, be read the third time and passed.

Health Care System June 11th, 2002

Mr. Chairman, accountability is an absolutely key issue here. When we talk to Canadians about health care, they want to see greater efficiency among other things. The other thing they talk about a lot is accountability. They want to know who they can hold accountable for the expenditure of their tax dollars. Is it the provincial minister of health, the federal Minister of Health, or the regional health authority? Is it the doctor from whom they have received a service? Who in fact is accountable in this system?

The hon. member raises an important point, which is that we need to do more together. That is why the provinces are moving in this area and certainly we will work with them to the greatest extent possible to ensure greater accountability and transparency in our health care system.

Health Care System June 11th, 2002

Mr. Chairman, I can reassure the hon. member that I am the Minister of Health and I have one task and one task only, and that is to discharge my obligations as the Minister of Health. One of the most important obligations I have right now is to work with provinces, territories, members of the House, health care professionals and those who use the system to renew the health care system.

I would hope that the hon. member, with her sophisticated knowledge, and I mean this quite sincerely, of the health care system would not suggest that the renewal of this system is only about cash, because it is not. There is no one that I have talked to who has suggested that renewal is only about cash.

I will certainly make a commitment to the people of Canada and to the members of the House that the Romanow commission's report will be made public by Mr. Romanow. We will take up that report and we, as a government, will begin the development of our plan of action with the provinces, territories, and with those who choose to respond to that report, including I am sure the Standing Committee on Health.

Health Care System June 11th, 2002

In fact, Mr. Chairman, the accord of 2000 entered into between the Prime Minister and the premiers of the provinces and the territories included the commitment of the $1 billion to the medical equipment fund. The agreement is quite clear that provinces in receipt of that money must account to their citizens, their residents. They are not accountable directly, and the agreement states this, to us, the federal government, but to the people of the country and particularly to the people who live in their provinces. They all undertook to account. In fact they have all communicated with my predecessor, who wrote to them twice. I am in possession of letters from all provincial and territorial health ministers.

Are they in different stages in terms of using the funds? Yes, they are. For example, from the province of Quebec we heard an announcement yesterday, I believe, that their remaining $100 million of federal dollars, along with additional funds from the province, will be dispensed. They made announcements yesterday about the funding of high tech equipment in various regional health facilities across the province of Quebec. This is happening across the country.

I want to reassure the hon. member that to the best of our knowledge at this point, the money in fact has not been spent. Please do not say that the money is not accounted for. The provinces and the territories have drawn down all their money from the fund that was established by the Department of Finance. Have they all spent it at this point? No. Have they all written the cheques for the equipment they have ordered at this point? No. Certainly we will be watching very carefully to ensure that the money is spent as was originally intended. I am aware of some of the concerns around what some of the money may have been spent for. This is something that I have asked my deputy minister to pursue with the respective provincial deputy ministers.

Health Care System June 11th, 2002

Obviously, Mr. Chairman, the funding of our health care system is an important issue, but I am one of those who believes that simply putting more money into the system is not going to lead to the renewal of the system that will make it sustainable well into the future.

However, let me say that no one should forget that we put $21.1 billion, which were new dollars, into health care in the accord entered into by our Prime Minister and the premiers in September 2000. As well, we have put in additional dollars, not insignificant dollars, for example, $1 billion for the medical equipment fund, close to $800 million in terms of a primary health care transition fund, and half a billion dollars for work with the provinces toward the creation of an electronic health record. All of these are important financial contributions.

That is not even to include the funds we provide through many sources for the basic research in the country that will ensure we have the knowledge to provide the basis for a sustainable health care system in the future.

I understand the hon. member's point. Obviously the financing of the system is something that we will continue to discuss in good faith with the provinces.

Health Care System June 11th, 2002

Mr. Chairman, it is a pleasure to participate in this take note debate in the House tonight. It is an important opportunity for all members to discuss the review of the Canadian health care system by the Romanow Commission.

I rise this evening to participate in this special take note debate on the future of health care in Canada. As all members are aware, on April 4, 2001, the Prime Minister announced the creation of the commission on the future of health care in Canada, to be chaired by former Saskatchewan premier Mr. Roy Romanow. Commissioner Romanow's mandate is to “recommend policies and measure to ensure over the long term the sustainability of our universally accessible, publicly funded health system that offers quality services to Canadians”.

His mandate could not be more important. This is clear from the overwhelming public involvement in the commissioner's activities over the past few months as he has undertaken the second and final phase of his work, a dialogue with the Canadian public and interested stakeholders. The commissioner has heard thoughtful and carefully considered submissions from citizens about their experiences within the health care system, including members of aboriginal communities, and from health care providers about the challenges they face in providing care to the best of their abilities.

This take note debate and the commissioner's recent public meetings with members of parliament, unprecedented, by the way, in the history of royal commissions in this country, are equally a reflection of the importance of this work.

Allow me, Mr. Chairman, to recognize and thank my colleagues in the House for the time and effort they have taken to consult with their constituents about the renewal of our health care system and to communicate their views to the commissioner and to me. I invite them to continue this very important work.

I also want to acknowledge the important contributions to this national debate made by recent provincial and territorial commissions and public consultations, by the National Health Forum in 1997 and by the Senate Standing Committee on Social Affairs, Science and Technology, led by Senator Michael Kirby.

The challenge we all face, citizens, Commissioner Romanow, members of parliament, our provincial and territorial colleagues and others, is to renew and reinvigorate our cherished health care system so that we can all have confidence that it will be there for us when we need it, providing timely access to high quality care.

Members will understand that I am not in a position this evening to talk about the specific steps we should take to improve our health care system. For that, we must await the delivery of Commissioner Romanow's final report in November and the careful deliberations that will follow. What I can and do want to talk about right now, though, is values.

I agree with Commissioner Romanow, as he has stated many times through the course of his public hearings, that the health care renewal debate is first and foremost a debate about values. As a nation we face three very tough questions. What should our health care system include? How should our health care services be delivered? How should we pay for our health care system?

As members of parliament charged with the responsibility of giving voice to the concerns and opinions of our constituents, our starting point in answering these questions has to be this fundamental question: What values do Canadians want to see reflected in their health care system?

What I hear Canadians saying loud and clear is that their core values are shared risk and equality of access. Taken together, these values may be equated to a strong sense of solidarity. It is through our health care system, better than anything else in the minds of most Canadians, that we reflect our solidarity with each other, with our family members, within our communities, as between our provinces and territories, and within our country. We also know that Canadians want a health care system that is publicly administered. The government must and will keep these core values foremost in its mind as we move forward.

Canadians also put a very high premium on the need for the federal government to demonstrate leadership in creating and maintaining national standards that give shape to the bedrock values of shared risk and equality of access. The government of Prime Minister Pearson played an historic role in this regard, introducing the Hospital Insurance and Diagnostic Services Act, which received unanimous support as it passed into law on April 10, 1957, and provided the foundation of our national public and universal health care system.

The government takes very seriously its responsibilities as guardian of the governing principles of our health care system as set out in the Canada Health Act: universality, accessibility, comprehensiveness, public administration and portability. This is a challenge within our federation, in which the provinces and territories are primarily responsible for the delivery of health care on a day to day basis. It is, however, a challenge that can and will be met with good faith and respect on all sides.

Canadians are fed up with governments arguing with one another over blame, money and jurisdiction, worrying that the object of this bickering, their most cherished social program, is sliding away from them for lack of concerted action on the part of those entrusted to govern. The federal government will not let Canadians down.

Canadians are pragmatic in the very best sense of that word. They understand that our health care system is not functioning as well as it can or should and they are realistic about the need for change. They are prepared to make the changes necessary to ensure that our health care system is sustainable for the future, as long as those changes are consistent with their values.

On these very important questions, I look forward to the advice I will receive from Commissioner Romanow when he delivers his final report in November of this year. I obviously also look forward to the views of members of the House on all sides this evening. For all of us, citizens, health care providers, members of parliament and our provincial and territorial colleagues, the process of health care renewal that lies ahead will put a premium on our intelligence, our goodwill and our spirit of partnership. I am confident that we will once more rise to the challenge.

Pest Control Products Act June 10th, 2002

moved that the bill be concurred in at report stage.

Aboriginal Affairs June 7th, 2002

Mr. Speaker, we are not abdicating our responsibility. As I said, as soon as it became known that public funds may have been misused, action was taken. We are proceeding. We have taken two court actions against the Virginia Fontaine addiction centre.

Let me reassure this hon. member that we take this situation very seriously. We will do everything in our power to ensure that aboriginal children and others are not put at risk.

Aboriginal Affairs June 7th, 2002

Mr. Speaker, my predecessor, as soon as it became known to him that there was an alleged misuse of public funds, took immediate action. We are now relying on two national firms of chartered accountants to conduct audits in accordance with professional standards.

It is very clear to us that this is indeed a troubling and difficult situation. We are acting expeditiously to ensure: first, that these kinds of things do not happen again; and, second, that--

Question No. 155 June 6th, 2002

Health Canada does not currently have a formal system in place to track non-approved veterinary drugs that are being used in animals in Canada. Anecdotal data are available which indicates some extra-label use of drugs, drugs used for purposes other than approved usage, as well as importation of non-approved veterinary drugs for use on animals.

As part of its strengthening exercise, the veterinary drugs directorate of Health Canada will be conducting a survey this summer and fall on the extra label use of veterinary drugs in Canada. This is a major step in addressing this issue.

Efforts are also underway to step up investigation and interception of cases where unapproved products are being imported or sold in Canada. Results of monitoring by the Canadian Food Inspection Agency, CFIA, for violative residues of veterinary drugs in food have shown consistently high compliance.

Discussions are well underway between Health Canada and the CFIA to develop a memorandum of understanding. This agreement will be in place by the fall of 2002 and implemented by April 2003.

Health Canada does not currently have a tracking system in place to monitor how active pharmaceutical ingredients, APIs, are being used in animals in Canada. Again, only anecdotal information is available at this time.

Health Canada's health products and food branch inspectorate is presently enforcing a policy which restricts the extent and the purposes for which APIs can be imported into Canada.

(d) We do not have specific information from Canada Customs and Revenue Agency on the importation of these products. The current policy on personal importation applies to drugs for human use only and not for drugs intended for veterinary use.

There is anecdotal information that veterinary drug products are being imported under this policy which are not for personal use but which are being sold or used by veterinarians to treat food producing animals. For this reason, Health Canada’s veterinary drugs directorate is developing a policy to address the importation of veterinary drug products. Prescription veterinary drugs can only be imported into Canada by animal owners.

Again, foods are regularly and systematically analyzed by the CFIA for veterinary drug residues to ensure compliance with Canadian regulations.